Sunil S. Iyengar

Charterhouse Square
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 82 publications

Individualised but Specific Exercise Training Improves Physiologic Reserve and Reduces Frailty in Older Adults with Chronic Lymphocytic Leukaemia: A 12-Week Pragmatic Randomised Controlled Trial.

Individualised but Specific Exercise Training Improves Physiologic Reserve and Reduces Frailty in Older Adults with Chronic Lymphocytic Leukaemia: A 12-Week Pragmatic Randomised Controlled Trial.

Journal: medRxiv : the preprint server for health sciences

Published: August 20, 2026

Glofitamab and epcoritamab for large B cell lymphoma: a real-world retrospective UK analysis of efficacy, tolerability, and impact of treatment sequencing.

Glofitamab and epcoritamab for large B cell lymphoma: a real-world retrospective UK analysis of efficacy, tolerability, and impact of treatment sequencing.

Journal: Haematologica

Published: January 21, 2026

Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.

Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.

Journal: Blood

Published: January 05, 2026

Updated consensus guidelines for the diagnosis and management of patients with hairy cell leukemia (HCL) and HCL-variant.

Updated consensus guidelines for the diagnosis and management of patients with hairy cell leukemia (HCL) and HCL-variant.

Journal: Blood

Published: January 05, 2026

Bridging practices prior to brexucabtagene autoleucel for mantle cell lymphoma in the United Kingdom: An analysis of modality, response, toxicity and survival.

Bridging practices prior to brexucabtagene autoleucel for mantle cell lymphoma in the United Kingdom: An analysis of modality, response, toxicity and survival.

Journal: British journal of haematology

Published: October 10, 2025

Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-up.

Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-up.

Journal: Blood advances

Published: September 17, 2025

Epcoritamab for Relapsed/Refractory EBV+ Post-Transplant Lymphoproliferative Disorder of DLBCL-Type.

Epcoritamab for Relapsed/Refractory EBV+ Post-Transplant Lymphoproliferative Disorder of DLBCL-Type.

Journal: EJHaem

Published: July 03, 2025

Physical Activity, Symptoms, Quality of Life and Exercise Program Preferences in People With Chronic Lymphocytic Leukaemia.

Physical Activity, Symptoms, Quality of Life and Exercise Program Preferences in People With Chronic Lymphocytic Leukaemia.

Journal: EJHaem

Published: June 16, 2025

Involvement of the gastrointestinal tract by mantle cell lymphoma.

Involvement of the gastrointestinal tract by mantle cell lymphoma.

Journal: British journal of haematology

Published: May 15, 2025

2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemia.

2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemia.

Journal: British journal of haematology

Published: May 05, 2025

CD19 chimeric antigen receptor T-cell efficacy and toxicity in adults with Richter's transformation and response to bridging therapy.

CD19 chimeric antigen receptor T-cell efficacy and toxicity in adults with Richter's transformation and response to bridging therapy.

Journal: British journal of haematology

Published: March 01, 2025

UK clinical practice guidelines for the management of patients with constitutional POT1 pathogenic variants.

UK clinical practice guidelines for the management of patients with constitutional POT1 pathogenic variants.

Journal: Journal of medical genetics

Published: January 14, 2025

Showing 1-12 of 82

Last Updated: 09/26/2026